Taro Pharmaceuticals U.S.A., Inc. recalls Ibuprofen Oral Suspension USP, 100 mg/5 mL, 4 fl. oz., (118 mL), Rx only, Manufactured by: Taro Pharmaceuticals, Inc.,…
- Recall date
- September 27, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0298-2020
- FDA classification
- Class II
- Brand / firm
- Taro Pharmaceuticals U.S.A., Inc.
- Sold / distributed
- U.S.A. Nationwide
Why it was recalled
Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Ibuprofen Oral Suspension USP, 100 mg/5 mL, 4 fl. oz., (118 mL), Rx only, Manufactured by: Taro Pharmaceuticals, Inc., Brampton, Ontario, Canada L6T 1C1, Distributed by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-1385-8
Get recall alerts
Free email alert whenever Taro Pharmaceuticals U.S.A., Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Taro Pharmaceuticals U.S.A., Inc.